[29, 30, 31] Risk factors: Diabetes (especially in combination with SGLT2 inhibitors use) Reduced oral intake and severe GI symptoms Dehydration Presentation: Nausea, vomiting, abdominal pain Anion gap metabolic acidosis Elevated ketones Normal or mildly elevated glucose Key point: EDKA has not been observed in non-diabetic patients in large cohort data
Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG
Glucuronidation This phase II reaction is one of the most common and important metabolizing drug reactions
Bar Beauty Medical, 46 Fort York Blvd, Toronto.
MmSNX1 does not interact with AtSNX1 or AtSNX2 in Y2H assays, unlike AtSNX1, which interacts with both AtSNX1 and AtSNX2 (Supplementary Fig
Storage: sealed amber-glass vial under inert gas